Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral midazolam for pain relief during nasogastric tube insertion
IRCT20110629006922N4Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of midazolam in Pain associated with nasogastric tube insertion (2 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoints: Pain severity during nasogastric tube insertion and Patient satisfaction with nasogastric tube insertion. Started Oct 2018; status: completed.
02
Drugs
midazolam
03
Conditions
Pain associated with nasogastric tube insertion
Beyond the preview
Go deeper on IRCT20110629006922N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110629006922N4.